JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
KW
2576
DELISTED
Kennedy-Wilson Holdings
KW
| $4.36M | ﹤0.01% |
203,977
+6,100
| +3% | +$124K |
2015 Q1
16 quarters
|
|
2577
CALL
Capital One
COF
$120B
| $4.35M | ﹤0.01% |
53,300
+52,900
| +13,225% | +$4.3M |
2018 Q4
1 quarter
|
|
|
VRN
2578
DELISTED
Veren
VRN
| $4.34M | ﹤0.01% |
1,340,582
-239,799
| -15% | -$739K |
2014 Q1
20 quarters
|
|
2579
Ryder
R
$9.06B
| $4.33M | ﹤0.01% |
69,894
-26,697
| -28% | -$1.56M |
2013 Q2
23 quarters
|
|
|
MRSN
2580
DELISTED
Mersana Therapeutics
MRSN
| $4.33M | ﹤0.01% |
32,935
+15,944
| +94% | +$2.01M |
2017 Q2
7 quarters
|
|
2581
Sensient Technologies
SXT
$5.66B
| $4.33M | ﹤0.01% |
63,889
-25,837
| -29% | -$1.63M |
2013 Q2
23 quarters
|
|
2582
PUT
Sarepta Therapeutics
SRPT
$1.83B
| $4.33M | ﹤0.01% |
36,300
+9,300
| +34% | +$1.2M |
2018 Q2
3 quarters
|
|
2583
PUT
Novartis
NVS
$268B
| $4.33M | ﹤0.01% |
50,220
| – | – |
2018 Q4
1 quarter
|
|
2584
HUB Group
HUBG
$1.72B
| $4.32M | ﹤0.01% |
211,682
-168,268
| -44% | -$3.59M |
2013 Q2
23 quarters
|
|
2585
OraSure Technologies
OSUR
$260M
| $4.32M | ﹤0.01% |
387,522
+27,388
| +8% | +$317K |
2015 Q4
13 quarters
|
|
2586
CALL
Archer Daniels Midland
ADM
$39.6B
| $4.31M | ﹤0.01% |
100,000
-132,500
| -57% | -$5.67M |
2018 Q2
3 quarters
|
|
2587
PUT
Pinnacle West Capital
PNW
$11.9B
| $4.31M | ﹤0.01% |
+45,100
| New | +$4.07M |
2019 Q1
0 quarters
|
|
|
GLDD
2588
DELISTED
Great Lakes Dredge & Dock
GLDD
| $4.31M | ﹤0.01% |
483,325
+468,746
| +3,215% | +$3.64M |
2016 Q4
9 quarters
|
|
2589
KT
KT
$9.05B
| $4.31M | ﹤0.01% |
346,078
+99,232
| +40% | +$1.35M |
2017 Q2
7 quarters
|
|
2590
State Street Communication Services Select Sector SPDR ETF
XLC
$23.2B
| $4.29M | ﹤0.01% |
91,697
-6,861
| -7% | -$313K |
2018 Q3
2 quarters
|
|
|
UNT
2591
DELISTED
UNIT Corporation
UNT
| $4.28M | ﹤0.01% |
300,434
-259,064
| -46% | -$4.12M |
2013 Q2
23 quarters
|
|
|
SYKE
2592
DELISTED
SYKES Enterprises Inc
SYKE
| $4.28M | ﹤0.01% |
151,220
+7,439
| +5% | +$210K |
2013 Q2
23 quarters
|
|
|
TOWR
2593
DELISTED
Tower International, Inc.
TOWR
| $4.26M | ﹤0.01% |
202,745
+8,885
| +5% | +$228K |
2013 Q3
22 quarters
|
|
2594
PUT
Vodafone
VOD
$38.3B
| $4.26M | ﹤0.01% |
234,500
-1,114,100
| -83% | -$20.7M |
2018 Q1
4 quarters
|
|
2595
Wipro
WIT
$16.6B
| $4.25M | ﹤0.01% |
2,136,100
+1,396,044
| +189% | +$2.84M |
2013 Q2
23 quarters
|
|
2596
CALL
CME Group
CME
$97.2B
| $4.25M | ﹤0.01% |
25,800
| – | – |
2017 Q4
5 quarters
|
|
|
2597
PUT
CME Group
CME
$97.2B
| $4.25M | ﹤0.01% |
25,800
-55,000
| -68% | -$9.72M |
2017 Q4
5 quarters
|
|
2598
Surgery Partners
SGRY
$1.76B
| $4.24M | ﹤0.01% |
375,879
+86,052
| +30% | +$1.08M |
2016 Q4
9 quarters
|
|
2599
Cheesecake Factory
CAKE
$5.39B
| $4.23M | ﹤0.01% |
86,435
-5,899
| -6% | -$271K |
2013 Q2
23 quarters
|
|
2600
Iovance Biotherapeutics
IOVA
$5.87B
| $4.23M | ﹤0.01% |
444,644
-4,725
| -1% | -$45.9K |
2017 Q2
7 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.